Carcinoma of the endometrium: Do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?

International Journal of Gynecological Pathology

Volumn 15, Issue 3, 1996, Pages 191-201

  Nordstrom B ^a   Strang, P ^a   Lindgren, A ^b   Bergstrom R ^c   Tribukait, B ^d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Endometrial carcinoma; Flow cytometry; Histopathological grading; Nuclear grading; Prognosis; Reproducibility

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; UTERUS CARCINOMA; WORLD HEALTH ORGANIZATION;

EID: 0029889344     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199607000-00002     Document Type: Article

References (39)

1. Christopherson WM. The significance of the pathologic findings in endometrial cancer. Clin Obstet Gynecol 1986;13:673-93.
2. Langley FA, Baak JPA. Quantitative methods in diagnostic gynaecological pathology. Clin Obstet Gynecol 1984;11:79-92.
3. FIGO: Classification and staging of malignant tumors in the female pelvis. Int J Gynecol Obstet 1971;9:172-9.
4. FIGO stages-1988 revisions: Vulva, ovary, corpus. Gynecol Oncol 1989;35:125-7.
5. Poulsen H, Taylor CW, Sobin LH. Histological typing of female genital tract tumors. International histologic classification of tumors. Geneva, Switzerland: World Health Organization, 1975:63-73.
6. Sobin LH, Thomas LB, Constance P, Henson D. A coded compendium of international histological classification of tumours. Ep. 11. Geneva, Switzerland: World Health Organization, 1978.
7. Kurman RJ, Norris HJJ. Endometrial carcinoma. In: Kurman RJ, ed. Blaustein's pathology of female genital tract. 3rd ed. New York: Springer-Verlag, 1987:338,344,361.
8. Benediktsdottir KR, Jonasson JG, Hallgrimsson J. Tumors in Iceland. XII. Malignant tumours of the corpus of uterus. APMIS 1989;97:781-6.
9. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol 1982;13:376-92.
10. Connelly PJ, Alberhasky RC, Christopherson WM. Carcinoma of the endometrium III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 1982;59:569-75.
11. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium. II. papillary adenocarcinoma: a clinical pathological study 46 cases. Am J Clin Pathol 1982;77:534-40.
12. Christopherson W, Connelly P, Alberhasky R. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 1983;51:1705-9.
13. Rosenberg P, Risberg B, Simonsen E. The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade, and nuclear grade. Acta Obstet Gynecol Scand 1989;68:157-63.
14. Schneider ML, Morphological criteria for prognosis of endometrial carcinoma with special regard to nuclear grading. Eur J Gynaec Oncol 1988;3:215-21.
15. Sorbe B, Risberg B, Frankendal B. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinomas. Gynecol Oncol 1990;38:22-7.
16. Sorbe B, Risberg B, Thomthwaite J. Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 1994;4:94-100.
17. Stendahl U, Strang P, Wagenius G, Bergström R, Tribukait B. Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 1991;10:271-84.
18. Ikeda M, Watanabe Y, Nanjoh T, Noda K. Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 1993;50:25-9.
19. Melchiorri C, Chieco P, Lisignoli G, Marabini A, Orlandi C. Ploidy disturbances as an early indicator of intrinsic malignancy in endometrial carcinoma. Cancer 1993;72:165-72.
20. Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984;5:430-6.
21. Wagenius G, Bergström R, Strang P, et al. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res 1992;12:725-32.
22. Symonds DA. Prognostic value of pathologic features and DNA analysis in endometrial carcinoma. Gynecol Oncol 1990;39:272-6.
23. Rosenberg P, Risberg B, Simonsen E, The prognostic importance of uterine papillary serous carcinoma, FIGO grade, nuclear grade, and age on endometrial carcinoma stage I and II. Acta Obstet Gynecol Scand 1989;68:157-63.
24. Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: Koss L, Coleman D, eds. Advances in clinical cytology. Vol. 2. New York: Masson, 1984:163-89..
25. Heiden T, Strang P, Stendahl U, Tribukait B. Reproducibility of flow cytometric analyses in human malignancies. Anticancer Res 1990;10:49-54.
26. Castro J, Heiden T, Wang N, Tribukait B. Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 1993;14:793-804.
27. Kjellgren O, Jonsson L. Further development of the Heyman radium packing method. Acta Radiol 1964;3:143-51.
28. Lawless JF. Statistical models and methods for life-time data. New York: Wiley, 1982.
29. DiSaia P, Creasman W. Management of endometrial carcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynecol 1986;11:751-65.
30. DiSaia P, Creasman W, Boronow R, Blessing J. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009-15.
31. Geisinger K, Kute T, Marshall R, Morgan T. Analysis of the relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of endometrium. Am J Clin Pathol 1986;85:536-41.
32. Stendahl U, Wille'n H, Wille'n R.Invasive squamous cell carcinoma of the uterine cervix. Reproducibility of a histopathologic malignancy grading system. Acta Radiol Oncol 1981;20:65-70.
33. Tiitinen A, Forss M, Aho I, Vesterinen E, Nieminen U. Endometrial adenocarcinoma: clinical outcome in 881 patients and analysis of 146 patients whose death were due to the endometrialcancer. Gynecol Oncol 1986;25:11-9.
34. Strang P, Stenkvist B, Bergström R, Stendahl U, Valdes del Campo M, Tribukait B. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study. Anticancer Res 1991;11:783-88.
35. Abeler V. Endometrial carcinoma in Norway. A study of a total population. Cancer 1991;67:3093-103.
36. Quinn M, Kneale B, Fortune D. Endometrial carcinoma in premenopausal women: a clinicopathological study. Gynecol Oncol 1985;20:298-306.
37. Beckner M, Mori T, Silverberg G. Endometrial carcinoma: Nontumor factors in prognosis. Int J Gynecol Pathol 1985;4:131-45.
38. Strang P, Stendahl U, Tribukait B, Wagenius G, Boman K. Age, menopausal status and DNA content in endometrial carcinoma. Anticancer Res 1989;9:1079-82.
39. Abeler V. Endometrial carcinoma in Norway. Morphology and prognosis. Th 1991. Norwegian Cancer Society, ISBN 82-90187 76-9.